Heart Test Laboratories Inc. (NASDAQ: HSCS) kicked off on Tuesday, up 4.16% from the previous trading day ,before settling in for the closing price of $0.11. Over the past 52 weeks, HSCS has traded in a range of $0.10-$1.49.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -56.05%. While this was happening, its average annual earnings per share was recorded 75.00%. With a float of $43.72 million, this company’s outstanding shares have now reached $65.56 million.
Let’s determine the extent of company efficiency that accounts for 12 employees.
Heart Test Laboratories Inc. (HSCS) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Heart Test Laboratories Inc. is 33.32%, while institutional ownership is 1.84%.
Heart Test Laboratories Inc. (HSCS) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 1/30/2024, the organization reported -$0.03 earnings per share (EPS), higher than consensus estimate (set at -$0.06) by $0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 75.00% per share during the next fiscal year.
Heart Test Laboratories Inc. (NASDAQ: HSCS) Trading Performance Indicators
Take a look at Heart Test Laboratories Inc.’s (HSCS) current performance indicators. Last quarter, stock had a quick ratio of 4.32. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 369.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.48, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.10 in one year’s time.
Technical Analysis of Heart Test Laboratories Inc. (HSCS)
Looking closely at Heart Test Laboratories Inc. (NASDAQ: HSCS), its last 5-days average volume was 0.85 million, which is a drop from its year-to-date volume of 2.67 million. As of the previous 9 days, the stock’s Stochastic %D was 39.39%. Additionally, its Average True Range was 0.01.
During the past 100 days, Heart Test Laboratories Inc.’s (HSCS) raw stochastic average was set at 5.64%, which indicates a significant decrease from 39.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.56% in the past 14 days, which was lower than the 124.58% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.1235, while its 200-day Moving Average is $0.3935. However, in the short run, Heart Test Laboratories Inc.’s stock first resistance to watch stands at $0.1149. Second resistance stands at $0.1170. The third major resistance level sits at $0.1213. If the price goes on to break the first support level at $0.1085, it is likely to go to the next support level at $0.1042. Should the price break the second support level, the third support level stands at $0.1021.
Heart Test Laboratories Inc. (NASDAQ: HSCS) Key Stats
The company with the Market Capitalisation of 7.39 million has total of 65,562K Shares Outstanding. Its annual sales at the moment are 10 K in contrast with the sum of -6,350 K annual income. Company’s last quarter sales were recorded 10 K and last quarter income was -1,640 K.
